Q32 Bio
QTTB
119 hedge funds and large institutions have $252M invested in Q32 Bio in 2021 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 29 reducing their positions, and 14 closing their positions.
64% more call options, than puts
Call options by funds: $1.42M | Put options by funds: $866K
24% more repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 29
14% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 14
5% more capital invested
Capital invested by funds: $240M → $252M (+$12.4M)
1% more funds holding
Funds holding: 118 → 119 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.09% less ownership
Funds ownership: 3.21% → 3.12% (-0.09%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Temasek Holdings
Singapore
|
+$16.8M |
| 2 |
Two Sigma Investments
New York
|
+$1.14M |
| 3 |
State Street
Boston,
Massachusetts
|
+$989K |
| 4 |
BlackRock
New York
|
+$799K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$650K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$11.4M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.54M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.02M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$2.95M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$1.65M |
QTTB Hedge Fund Activity: Q3 2021 in Review
119 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q3 2021, worth a combined $252M — up 5.2% from $240M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new QTTB positions and 14 closed out — a net gain of 2 holders — while 36 added to existing stakes and 29 trimmed.
The largest buyer was Temasek Holdings, adding an estimated $16.8M. The largest seller was Wellington Management Group, cutting an estimated $11.4M.
- 119 institutional investors held Q32 Bio (QTTB) as of Q3 2021, up from 118 in Q2 2021.
- Funds reported $252M of Q32 Bio stock for Q3 2021, up 5.2% quarter-over-quarter.
- 16 funds opened new Q32 Bio positions in Q3 2021 and 14 closed out, a net change of +2 holders.
- The largest Q32 Bio buyer in Q3 2021 was Temasek Holdings, an estimated $16.8M added.
- The largest Q32 Bio seller in Q3 2021 was Wellington Management Group, an estimated $11.4M sold.
Based on aggregated 13F filings for Q3 2021.